Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial


      Regional nodal irradiation for women with breast cancer is known to be an important risk factor for the development of upper extremity lymphedema, but tools to accurately predict lymphedema risks for individual patients are lacking. This study sought to develop and validate a nomogram to predict lymphedema risk after axillary surgery and radiation therapy in women with breast cancer.

      Methods and Materials

      Data from 1832 women accrued on the MA.20 trial between March 2000 and February 2007 were used to create a prognostic model with National Cancer Institute Common Toxicity Criteria Version 2.0 grade 2 or higher lymphedema as the primary endpoint. Multivariable logistic regression estimated model performance. External validation was performed on data from a single large academic cancer center (N = 785).


      In the MA.20 trial cohort, 3 risk factors were predictive of lymphedema risk: body mass index (adjusted odds ratio, 1.05 per unit body mass index; 95% confidence interval [CI], 1.03-1.08, P < .001), extent of axillary surgery (adjusted odds radio for 8-11 lymph nodes removed, 3.28 [95% CI, 1.53-7.89] P = .004; 12-15 lymph nodes, 4.04 [95% CI, 1.76-10.26] P = .002; ≥16 nodes, 5.08 [95% CI, 2.26-12.70] P < .001), and extent of nodal irradiation (adjusted odds radio for limited, 1.66 [95% CI, 1.08-2.56] P = .02; for extensive, 2.31 [95% CI, 1.28-4.10] P = .004). A nomogram was created from these data that predicted lymphedema risk with reasonable accuracy confirmed by both internal (concordance index, 0.69; 95% CI, 0.64-0.74) and external validation (concordance index, 0.71; 95% CI, 0.66-0.76).


      The nomogram created from the MA.20 randomized trial data using clinical information may be useful for lymphedema screening and risk stratification for therapeutic intervention trials.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Darby S.
        • McGale P.
        • Correa C.
        • et al.
        Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomized trials.
        Lancet. 2011; 378: 1707-1716
        • Recht A.
        • Comen E.A.
        • Fine R.E.
        • et al.
        Postmastecomy radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update.
        Pract Radiat Oncol. 2016; 6: e219-e234
        • Poortmans P.M.
        • Collette S.
        • Kirkove C.
        • et al.
        Internal mammary and medial supraclavicular irradiation in breast cancer.
        N Engl J Med. 2015; 373: 317-327
        • Whelan T.J.
        • Olivotto I.A.
        • Parulekar W.R.
        • et al.
        Regional nodal irradiation in early-stage breast cancer.
        N Engl J Med. 2015; 373: 307-316
        • Kwan W.
        • Jackson J.
        • Weir L.M.
        Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life.
        J Clin Oncol. 2002; 20: 4242-4248
        • Shah C.
        • Vicini F.A.
        Breast-cancer related arm lymphedema: Incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
        Int J Radiat Oncol Biol Phys. 2011; 81: 907-914
        • DiSipio T.
        • Rye S.
        • Newman B.
        • et al.
        Incidence of unilateral arm lymphedema after breast cancer: A systematic review and meta-analysis.
        Lancet Oncol. 2013; 14: 500-515
        • Deutsch M.
        • Land S.
        • Begovic M.
        • et al.
        The incidence of arm lymphedema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone.
        Int J Radiat Oncol Biol Phys. 2008; 70: 1020-1024
        • Gross J.P.
        • Sachdev S.
        • Helenowski I.B.
        • et al.
        Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer.
        Int J Radiat Oncol Biol Phys. 2018; 102: 71-78
        • Olivotto I.A.
        • Chua B.
        • Elliott E.A.
        • et al.
        A clinical trial of breast radiation therapy versus breast and regional radiation therapy in early-stage breast cancer: The MA20 Trial.
        Clin Breast Cancer. 2003; 4: 361-363
        • Collins G.S.
        • Reitsma J.B.
        • Altman D.G.
        • et al.
        Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.
        Ann Intern Med. 2015; 162: 55-63
        • van Buuren S.
        Multiple imputation of discrete and continuous data by fully conditional specification.
        Stat Methods Med Res. 2007; 16: 219-242
        • Moons K.G.
        • Altman D.G.
        • Reitsma J.B.
        • et al.
        Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): Explanation and elaboration.
        Ann Intern Med. 2015; 162: W1-W73
        • Mantel N.
        Why stepdown procedures in variable selection?.
        Technometrics. 1970; 12: 621-625
        • R Core Team
        R: a language and environment for statistical computing. R Foundation for Statistical Computing Vienna, Austria.
        (Available at:)
        Date accessed: May 3, 2019
        • van Buuren S.
        • Groothuis-Oudshoorn K.
        Mice: Multivariate imputation by chained equations in R.
        J Stat Softw. 2011; 45: 1-67
        • Harrell F.E.
        Rms: Regression modeling strategies. R package version 5.1-2.
        (Available at:) (Accessed July 6, 2018)
        • Steyerberg E.W.
        • Harrell Jr., F.E.
        • Borsboom G.J.
        • et al.
        Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis.
        J Clin Epidemiol. 2001; 54: 774-781
        • Janssen K.J.
        • Moons K.G.
        • Kalkman C.J.
        • et al.
        Updating methods improved the performance of a clinical prediction model in new patients.
        J Clin Epidemiol. 2008; 61: 76-86
        • Bevilacqua J.L.
        • Kattan M.W.
        • Changhong Y.
        • et al.
        Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
        Ann Surg Oncol. 2012; 19: 2580-2589
        • Kim M.
        • Kim S.W.
        • Lee S.U.
        • et al.
        A model to estimate the risk of breast cancer-related lymphedema: Combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
        Int J Radiat Oncol Biol Phys. 2013; 86: 498-503
        • Donker M.
        • van Tienhoven G.
        • Straver M.E.
        • et al.
        Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomized, multicenter, open-label, phase 3 non-inferiority trial.
        Lancet Oncol. 2014; 15: 1303-1310
        • Hurkmans C.W.
        • Borger J.H.
        • Rutgers E.J.
        • et al.
        Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: The dummy run.
        Radiother Oncol. 2003; 68: 233-240
        • Berg J.W.
        The significance of axillary node levels in the study of breast carcinoma.
        Cancer. 1955; 8: 776-778
        • Clough K.B.
        • Nasr R.
        • Nos C.
        • et al.
        New anatomical classification of the axilla with implications for sentinel node biopsy.
        Br J Surg. 2010; 97: 1659-1665
        • Grills I.S.
        • Kestin L.L.
        • Goldstein N.
        • et al.
        Risk factors for regional nodal failure after breast-conserving therapy: Regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
        Int J Radiat Oncol Biol Phys. 2003; 56: 658-670
        • Ancukiewica M.
        • Russell T.A.
        • Otoole J.
        • et al.
        Standardized method for quantification of developing lymphedema in patients treated for breast cancer.
        Int J Radiat Oncol Biol Phys. 2011; 79: 1436-1443
        • McDuff S.G.R.
        • Mina A.I.
        • Brunelle C.L.
        • et al.
        Timing of lymphedema after treatment for breast cancer: When are patients most at risk?.
        Int J Radiat Oncol Biol Phys. 2019; 103: 62-70


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.